市场调查报告书
商品编码
1619172
伴同性动物诊断市场规模、份额、成长分析、按技术、按动物类型、按应用、按最终用户、按地区 - 行业预测,2024-2031 年Companion Animal Diagnostics Market Size, Share, Growth Analysis, By Technology (Clinical biochemistry, Immunodiagnostics), By Animal Type (Dogs, Cats), By Application, By End User, By Region - Industry Forecast 2024-2031 |
2022年,伴同性动物诊断的全球市场规模为23亿美元,从2023年的25.3亿美元增长到2031年的53.4亿美元,在预测期内(2024-2031年)预计将以复合年增长率增长。 9.8%。
宠物慢性病盛行率的上升和诊断技术的进步预计将推动伴同性动物诊断市场的显着成长。据报道,从2012年到2022年,狗的糖尿病将增加40%,猫的糖尿病将增加30%,迫切需要有效的诊断。宠物拥有量的增加进一步推动了这个市场,超过 6,390 万家庭拥有至少一隻狗,约 5,200 万个家庭拥有一隻猫。此外,对自动化和半自动化诊断测试的需求正在迅速增加,从而提高了样品处理的效率。护理点诊断 (POCD) 等创新有望快速取得成果,而旨在改善兽医服务的政府倡议将支持长期市场扩张。到 2031 年,美国的动物保健费用预计将达到 330 亿美元。
Global Companion Animal Diagnostics Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.53 billion in 2023 to USD 5.34 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).
The growing prevalence of chronic disorders in pets, coupled with advancements in diagnostics, is poised to drive significant growth in the companion animal diagnostics market. Reports indicate a staggering 40% rise in canine diabetes and a 30% increase in feline diabetes from 2012 to 2022, reflecting an urgent need for effective diagnostics. The rising number of pet owners further supports this market, with over 63.9 million households owning at least one dog and around 52 million with cats. Additionally, the demand for automated and semi-automated diagnostic testing is surging, enhancing efficiency in sample handling. Innovations such as Point of Care Diagnostics (POCD) promise expedited results, while government initiatives aimed at improving veterinary services underpin long-term market expansion. The U.S. veterinary care expenditure is expected to reach USD 33 billion by 2031.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Companion Animal Diagnostics Market Segmental Analysis
Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Companion Animal Diagnostics Market
The Global Companion Animal Diagnostics market is witnessing significant growth driven by the increasing demand for rapid testing and portable diagnostic tools designed for point-of-care (PoC) services. These tools have become essential for veterinarians, facilitating the quick detection of animal illnesses, particularly in remote locations like homes or shelters, and during emergencies. Major manufacturers are focusing on developing innovative portable diagnostics that enhance workflow in veterinary hospitals and research institutions. Additionally, pet healthcare spending, including veterinary treatments and pet insurance, has surged, encouraging pet owners, especially in North America and Europe, to invest in comprehensive care for their animals. This surge in demand for efficient, cost-effective diagnostic solutions underpins the expansion of the market.
Restraints in the Global Companion Animal Diagnostics Market
The growth of the Global Companion Animal Diagnostics market may be hindered by escalating pet care expenses, particularly in developing nations where there is a shortage of veterinarians. These rising costs could deter pet owners from seeking necessary diagnostic services, ultimately impacting market expansion. Additionally, a general lack of awareness regarding animal healthcare poses a substantial challenge, preventing pet owners from recognizing the importance of regular diagnostics. Collectively, these factors will likely create significant obstacles for the companion animal diagnostics market during the projected period, impeding its potential for growth and advancement.
Market Trends of the Global Companion Animal Diagnostics Market
The Global Companion Animal Diagnostics market is witnessing a significant trend driven by heightened research and development efforts focused on the diagnostic capabilities for companion animals, especially in relation to SARS-CoV-2 exposure. As various animal species emerge as potential vectors for COVID-19, key health organizations, including the CDC and USDA, are actively engaging in monitoring and studying these vulnerabilities. This surge in research not only enhances understanding of the epidemiological impact on animal and human health but also stimulates innovation in diagnostic devices. Consequently, the market is anticipated to expand, reflecting an increased demand for advanced diagnostic solutions that ensure better health outcomes for companion animals.